Brief: Brooks Laboratories Says Board Approves Scheme Of Arrangement With Abridge Speciality
14/10/2026 16:04
BRIEF-Brooks Laboratories Says Board Approves Scheme Of Arrangement With Abridge Speciality Oct 14 (Reuters) - Brooks Laboratories Ltd BROO.NS:
BROOKS LABORATORIES - BOARD APPROVES SCHEME OF ARRANGEMENT WITH ABRIDGE SPECIALITY
BROOKS LABORATORIES LTD - DEMERGER OF MANUFACTURING BUSINESS OF BROOKS LABORATORIES INTO ABRIDGE SPECIALITY
BROOKS LABORATORIES - FOR EVERY 1 EQUITY SHARE IN BROOKS LABORATORIES, 1 EQUITY SHARE IN ABRIDGE SPECIALITY WILL BE ISSUED
Source text: ID:nBSE8tKYP6
Further company coverage: BROO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brooks Laboratories
See all newsBrief: Brooks Laboratories Says Board Approves Scheme Of Arrangement With Abridge Speciality
Brief: Brooks Laboratories Enters Binding MoU With Steriscience Specialties Pvt Ltd And Brooks Steriscience
Brief: Brooks Laboratories Appoints Prashant Rathi As CEO
Brief: Brooks Laboratories Names Prashant Rathi As CEO
Brief: Brooks Laboratories Approves Fund Raise Of Up To 750 Million Rupees